✦ LIBER ✦

PD27-11 A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF METHYLPHENIDATE FOR REDUCTION OF FATIGUE IN PROSTATE CANCER PATIENTS RECEIVING LHRH-AGONIST THERAPY

✍ Scribed by Richard, Patrick O.; Fleshner, Neil E.; Bhatt, Jaimin R.; Hersey, Karen M.; Chahin, Rehab; Alibhai, Shabbir M.H.

Book ID: 122180640
Publisher: Lippincott Williams and Wilkins
Year: 2014
Tongue: English
Weight: 43 KB
Volume: 191
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2014.02.2110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II, randomised, double-blind, plac

Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy

✍ Richard, Patrick O.; Fleshner, Neil E.; Bhatt, Jaimin R.; Hersey, Karen M.; Chah 📂 Article 📅 2015 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

846 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-

846 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DENOSUMAB IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR NON-METASTATIC PROSTATE CANCER

✍ M.R. Smith; B. Egerdie; Toriz N. Hernández; R. Feldman; T.L.J. Tammela; F. Saad; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Methylphenidate and/or a Nursing Telepho

Methylphenidate and/or a Nursing Telephone Intervention for Fatigue in Patients With Advanced Cancer: A Randomized, Placebo-Controlled, Phase II Trial

✍ Bruera, E.; Yennurajalingam, S.; Palmer, J. L.; Perez-Cruz, P. E.; Frisbee-Hume, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 114 KB

Randomized, Double-Blinded, Placebo-Cont

Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy

✍ Choo, Richard; Lukka, Himu; Cheung, Patrick; Corbett, Tom; Briones-Urbina, Rosar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Efficacy of vitamin D3 as add-on therapy

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

✍ Joost Smolders; Raymond Hupperts; Frederik Barkhof; Luigi M.E. Grimaldi; Trygve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 355 KB

P-238 Fatigue and plasma cytokines in a

P-238 Fatigue and plasma cytokines in a randomized double-blind placebo-controlled trial of epoetin alfa in patients undergoing combined modality therapy for unresetable non-small cell lung cancer (NSCLC)

✍ DiSalvo, Wendye M.; Beggs, Virginia L.; Meyers, Louise P.; Dragnev, Konstantin H 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 363 KB